Effects of Dexmedetomidine Infusion During Sevoflurane Anesthesia on Otoacoustic Emissions
1
조회
0
다운로드
0
인용
0
참고문헌
초록
Background and Objectives: Knowing the ototoxic potential of the agents used in medical treatments is important for the protection of hearing. Although we have knowledge regarding some effects of dexmedetomidine, which is an anesthetic-sparing drug, its influence over the hearing system has never been studied and is obscure yet. The aim of this study is to determine the effects of intravenous dexmedetomidine application during sevoflurane anesthesia on otoacoustic emissions (OAEs). Subjects and Methods: This prospective randomized study was performed on 60 patients (34 male, 26 female, mean age: 30.6±9.2 years) who were scheduled for an elective surgery under general anesthesia and the patients were enrolled and randomly divided into 2 groups. They received dexmedetomidine (Group D) or Saline (Group S) infusion during a standardized Sevoflurane anesthesia. Transient and distortion product OAEs were measured preoperatively and postoperatively (24th hour). OAE results were compared within and between groups. Results: In group D postoperative OAEs were lower than preoperative OAEs and postoperative levels of group S, especially at low frequencies (p<0.05). Conclusions: Dexmedetomidine infusion affects the micromechanical function of cochlea especially in the low-frequency region. Dexmedetomidine should be carefully used during general anesthesia to avoid its probable harmful effects on cochlear micromechanics.
Abstract
Background and Objectives: Knowing the ototoxic potential of the agents used in medical treatments is important for the protection of hearing. Although we have knowledge regarding some effects of dexmedetomidine, which is an anesthetic-sparing drug, its influence over the hearing system has never been studied and is obscure yet. The aim of this study is to determine the effects of intravenous dexmedetomidine application during sevoflurane anesthesia on otoacoustic emissions (OAEs). Subjects and Methods: This prospective randomized study was performed on 60 patients (34 male, 26 female, mean age: 30.6±9.2 years) who were scheduled for an elective surgery under general anesthesia and the patients were enrolled and randomly divided into 2 groups. They received dexmedetomidine (Group D) or Saline (Group S) infusion during a standardized Sevoflurane anesthesia. Transient and distortion product OAEs were measured preoperatively and postoperatively (24th hour). OAE results were compared within and between groups. Results: In group D postoperative OAEs were lower than preoperative OAEs and postoperative levels of group S, especially at low frequencies (p<0.05). Conclusions: Dexmedetomidine infusion affects the micromechanical function of cochlea especially in the low-frequency region. Dexmedetomidine should be carefully used during general anesthesia to avoid its probable harmful effects on cochlear micromechanics.
참고문헌 (29)
- Pawlowski K., "Ototoxicity", pp.1~19 (2004), BC Decker Inc
- Harel N, "The effects of anesthesia on otoacoustic emissions", Hear Res, 110, pp.25~33 (1997)
- Zheng Y, "Effect of anesthetic agents and middle ear pressure application on distortion product otoacoustic emissions in the gerbil", Hear Res, 112, pp.167~174 (1997)
- Albera R, "Cochlear blood flow modifications induced by anaesthetic drugs in middle ear surgery: comparison between sevoflurane and propofol", Acta Otolaryngol, 123, pp.812~816 (2003)
- Buyukkocak U, "Prospective randomized trial to determine whether inhalational anesthetics have any effects on hearing function", J Otolaryngol Head Neck Surg, 38, pp.495~500 (2009)
- Guven S, "Influence of anaesthetic agents on transient evoked otoacoustic emissions and stapedius reflex thresholds", J Laryngol Otol, 120, pp.10~15 (2006)
- Khan Z, "Alpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic role", Anaesthesia, 54, pp.146~165 (1999)
- Flacke JW, "Alpha 2-adrenergic agonists in cardiovascular anesthesia", J Cardiothorac Vasc Anesth, 6, pp.344~359 (1992)
- Memiş D, "Dexmedetomidine reduces rocuronium dose requirement in sevoflurane anaesthesia", Curr Anaesth Crit Care, 19, pp.169~174 (2008)
- Maier C, "Neuroprotection by the alpha 2-adrenoreceptor agonist dexmedetomidine in a focal model of cerebral ischemia", Anesthesiology, 79, pp.306~312 (1993)
- Zornow MH, "Dexmedetomidine, an α2-adrenergic agonist, decreases cerebral blood flow in the isoflurane-anesthetized dog", Anesth Analg, 70, pp.624~630 (1990)
- Hauser R, "Influence of general anesthesia on transiently evoked otoacoustic emissions in humans", Ann Otol Rhinol Laryngol, 101, pp.994~999 (1992)
- Zhang M, "Effects of middle ear pressure on otoacoustic emission measures", J Acoust Soc Am, 102(2 Pt 1), pp.1032~1037 (1997)
- Sun XM, "Effects of negative middle ear pressure on distortion product otoacoustic emissions and application of a compensation procedure in humans", Ear Hear, 30, pp.191~202 (2009)
- Uchida Y, "Distortion product otoacoustic emissions and tympanometric measurements in an adult population-based study", Auris Nasus Larynx, 33, pp.397~401 (2006)
- Nader ND, "Middle ear pressure changes after nitrous oxide anesthesia and its effect on postoperative nausea and vomiting", Laryngoscope, 114, pp.883~886 (2004)
- Ozturk O, "Effects of sevoflurane and TIVA with propofol on middle ear pressure", Int J Pediatr Otorhinolaryngol, 70, pp.1231~1234 (2006)
- Hansen S., "Postural hypotension-cochleo-vestibular hypoxia-deafness", Acta Otolaryngol Suppl, 449, pp.165~169 (1988)
- Pirodda A, "Hypotension and sensorineural hearing loss: a possible correlation", Acta Otolaryngol, 119, pp.758~762 (1999)
- Telischi FF, "Distortion-product otoacoustic emission monitoring of cochlear blood flow", Laryngoscope, 108, pp.837~842 (1998)
- Mom T, "Measuring the cochlear blood flow and distortion-product otoacoustic emissions during reversible cochlear ischemia: a rabbit model", Hear Res, 133, pp.40~52 (1999)
- Brown JN, "Autoregulation of cochlear blood flow in guinea pigs", Am J Physiol, 266(2 Pt 2), pp.H458~H467 (1994)
- Dagal A, "Cerebral autoregulation and anesthesia", Curr Opin Anaesthesiol, 22, pp.547~552 (2009)
- Ogawa Y, "Dexmedetomidine weakens dynamic cerebral autoregulation as assessed by transfer function analysis and the thigh cuff method", Anesthesiology, 109, pp.642~650 (2008)
- Kawano T, "Dexmedetomidine directly inhibits vascular ATP-sensitive potassium channels", Life Sci, 90, pp.272~277 (2012)
- Talke P, "Systemically administered alpha2-agonist-induced peripheral vasoconstriction in humans", Anesthesiology, 99, pp.65~70 (2003)
- Borin A, "Study of distortion-product otoacoustic emissions during hypothermia in humans", Braz J Otorhinolaryngol, 74, pp.401~409 (2008)
- Ferber-Viart C, "Influence of hyperthermia on cochlear micromechanical properties in humans", Hear Res, 91, pp.202~207 (1995)
- Seifert E, "The influence of hypothermia on outer hair cells of the cochlea and its efferents", Br J Audiol, 35, pp.87~98 (2001)